Clinical Trial Update: Phase II Open-Label Pilot Study of V3381 in Chronic Cough [Phase 2]

View source ↗

Summary

Phase II open-label pilot study of V3381 for chronic cough was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cough

Drugs mentioned

• V3381

Snippet

Sponsor: Vernalis (R&D) Ltd | Conditions: Cough | Phase 2 | Status: TERMINATED